Severe attack of ulcerative colitis in children: retrospective clinical survey

https://doi.org/10.1016/S1590-8658(02)80058-5Get rights and content

Abstract

Aim. To obtain clinical data concerning severe attacks of ulcerative colitis in children.

Patients and methods. A retrospective chart review of 37 children with ulcerative colitis was carried out in order to assess the prevalence, risk factors, timing of presentation, and outcome of severe attacks of ulcerative colitis.

Results. A total of 20 severe attacks occurred in 15 out of the 37 patients. No difference in the occurrence of severe attacks was detected in relation to age or disease extent at diagnosis. The mean interval between disease diagnosis and a severe attack was 9.1 months (range 0–30). Of the 20 severe attacks, 11 were resolved with medical treatment in a mean time of 11 ±4. 6 days while 9 out of 20 needed urgent surgery in a mean time of 7.4±4.8 days. Of 10 out of the 15 patients who recovered from the first attack 4 required colectomy after a mean time of 6.7 months, another 4 are still in remission at a mean period of 40.7 months, one needed elective surgery after 25 months and one was lost to follow-up.

Conclusions. Severe attacks of ulcerative colitis had a high prevalence rate (40%); age and disease extent at presentation were not predictors of their occurrence. Approximately half the attacks resolved with medical treatment alone, while the other half required emergency surgery. After successful medical treatment of the first attack, 40% of children maintained long-term remission, while 40% required early colectomy

References (18)

There are more references available in the full text version of this article.

Cited by (22)

  • Predicting Outcomes in Pediatric Ulcerative Colitis for Management Optimization: Systematic Review and Consensus Statements From the Pediatric Inflammatory Bowel Disease–Ahead Program

    2021, Gastroenterology
    Citation Excerpt :

    Age at diagnosis did not predict ASC in 2 retrospective studies of children with UC.27,44 One of these studies also found no association between ASC and disease extent.44 Statement 2.4.

  • Biological therapy in pediatric age

    2020, Pharmacological Research
    Citation Excerpt :

    Of the total of 33 patients receiving IFX, 76 % were able to be discharged without colectomy and had a cumulative 1-year sustained response rate of 55 % (18/33). The advent of IFX together with calcineurin inhibitors has reduced the short-term colectomy rate from 40 %–70 % [17,22], to approximately 10 %–20 % in children [23,24] and the 1-year colectomy rate from 60 % to 18 %–22 % [25]. In a retrospective study conducted by Iwanczak et al. [26] 42 children (4–18 years) with moderate-severe UC were included.

  • Management of acute severe ulcerative colitis in children

    2017, Seminars in Pediatric Surgery
    Citation Excerpt :

    One prospective multicenter pediatric cohort study of ASUC where patients received the aforementioned dose reported a 71% response rate (95% CI: 63–78%).15 An analysis of a large prospective study of 128 children and 4 retrospective studies (143 patients in total) reported that failure rates to IV corticosteroid therapy in ASUC ranged between 9% and 47%.6,9,15,55–57 A subsequent meta-analysis of the published data from these 5 studies yielded a pooled estimate failure rate of 34% (95% CI: 27–41%) which is higher compared to adults.9

  • Response to Corticosteroids in Severe Ulcerative Colitis: A Systematic Review of the Literature and a Meta-Regression

    2007, Clinical Gastroenterology and Hepatology
    Citation Excerpt :

    Well-validated predictive indices could play an important role in the guideline development.50-62

View all citing articles on Scopus
View full text